drugset / Trial / NCT04319263

Oncological Outcomes of Different Patterns of Tumor Recurrence at First Evaluation After Bacillus Calmette-Guérin Induction Therapy for Intermediate and High Risk Non Muscle Invasive Bladder Cancer

NCT04319263 ↗

Completed 1600 enrolled Mansoura University
NaSingle-groupOpen-labelTreatment

Summary

This retrospective study aimed at assessment of different patterns (morphological and pathological) of tumor recurrence found at first evaluation after BCG induction therapy (3 months cystoscopy) for intermediate and high-risk NMIBC and its prognostic implications at a tertiary referral center.

Timeline

Start
2020-03-01
Primary completion
2020-03-18
Completion
2020-03-18

Drugs

EvaluationDrugModalityDoseRoute
Subject BCG Unknown — Other